189 related articles for article (PubMed ID: 21548851)
1. The Val34Leu genetic variation in the A subunit of coagulation factor XIII in recurrent spontaneous abortion.
Bagheri M; Rad IA; Omrani MD; Nanbaksh F
Syst Biol Reprod Med; 2011 Oct; 57(5):261-4. PubMed ID: 21548851
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of the coagulation factor XIII polymorphism Val34Leu in women with recurrent miscarriage.
López Ramírez Y; Vivenes M; Miller A; Pulido A; López Mora J; Arocha-Piñango CL; Marchi R
Clin Chim Acta; 2006 Dec; 374(1-2):69-74. PubMed ID: 16844105
[TBL] [Abstract][Full Text] [Related]
3. The effect of the Val34Leu polymorphism in the factor XIII gene in infants with a birth weight below 1500 g.
Göpel W; Kattner E; Seidenberg J; Kohlmann T; Segerer H; Möller J;
J Pediatr; 2002 Jun; 140(6):688-92. PubMed ID: 12072871
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of factor XIII Val34Leu polymorphism in patients affected by spontaneous subconjunctival hemorrhage.
Parmeggiani F; Costagliola C; Incorvaia C; Gemmati D; D'Angelo S; Tognazzo S; Scapoli GL; Sebastiani A
Am J Ophthalmol; 2004 Sep; 138(3):481-4. PubMed ID: 15364237
[TBL] [Abstract][Full Text] [Related]
5. Genetic association between FXIII and β-fibrinogen genes and women with recurrent spontaneous abortion: a meta- analysis.
Li J; Wu H; Chen Y; Wu H; Xu H; Li L
J Assist Reprod Genet; 2015 May; 32(5):817-25. PubMed ID: 25862345
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of coagulation factor XIII and plasminogen activator inhibitor-1 gene polymorphisms among Egyptian women suffering from unexplained primary recurrent miscarriage.
Elmahgoub IR; Afify RA; Abdel Aal AA; El-Sherbiny WS
J Reprod Immunol; 2014 Jun; 103():18-22. PubMed ID: 24702949
[TBL] [Abstract][Full Text] [Related]
7. Factor XIII Val34Leu variant and the risk of myocardial infarction: a meta-analysis.
Shafey M; Anderson JL; Scarvelis D; Doucette SP; Gagnon F; Wells PS
Thromb Haemost; 2007 Apr; 97(4):635-41. PubMed ID: 17393027
[TBL] [Abstract][Full Text] [Related]
8. Turkish population data on the factor XIII Val34Leu,glycoprotein (GP)Ibalpha Kozak and P-selectin glycoprotein ligand 1 (PSGL-1) loci.
Hancer VS; Diz-Kucukkaya R; Nalcaci M
Cell Biochem Funct; 2005; 23(1):55-8. PubMed ID: 15386532
[TBL] [Abstract][Full Text] [Related]
9. Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis.
Van Hylckama Vlieg A; Komanasin N; Ariëns RA; Poort SR; Grant PJ; Bertina RM; Rosendaal FR
Br J Haematol; 2002 Oct; 119(1):169-75. PubMed ID: 12358922
[TBL] [Abstract][Full Text] [Related]
10. Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis.
Wells PS; Anderson JL; Scarvelis DK; Doucette SP; Gagnon F
Am J Epidemiol; 2006 Jul; 164(2):101-9. PubMed ID: 16740590
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of plasminogen activator inhibitor-1, angiotensin converting enzyme and coagulation factor XIII genes in patients with recurrent spontaneous abortion.
Aarabi M; Memariani T; Arefi S; Aarabi M; Hantoosh Zadeh S; Akhondi MA; Modarressi MH
J Matern Fetal Neonatal Med; 2011 Mar; 24(3):545-8. PubMed ID: 20822334
[TBL] [Abstract][Full Text] [Related]
12. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
de la Red G; Tàssies D; Espinosa G; Monteagudo J; Bové A; Plaza J; Cervera R; Reverter JC
Thromb Haemost; 2009 Feb; 101(2):312-6. PubMed ID: 19190815
[TBL] [Abstract][Full Text] [Related]
13. Risk for early pregnancy loss by factor XIII Val34Leu: the impact of fibrinogen concentration.
Dossenbach-Glaninger A; van Trotsenburg M; Oberkanins C; Atamaniuk J
J Clin Lab Anal; 2013 Nov; 27(6):444-9. PubMed ID: 24218126
[TBL] [Abstract][Full Text] [Related]
14. Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.
Marín F; Corral J; Roldán V; González-Conejero R; del Rey ML; Sogorb F; Lip GY; Vicente V
J Mol Cell Cardiol; 2004 Sep; 37(3):699-704. PubMed ID: 15350843
[TBL] [Abstract][Full Text] [Related]
15. Factor XIII val34leu and the risk of myocardial infarction.
Franco RF; Pazin-Filho A; Tavella MH; Simões MV; Marin-Neto JA; Zago MA
Haematologica; 2000 Jan; 85(1):67-71. PubMed ID: 10629595
[TBL] [Abstract][Full Text] [Related]
16. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases.
Gemmati D; Serino ML; Ongaro A; Tognazzo S; Moratelli S; Resca R; Moretti M; Scapoli GL
Am J Hematol; 2001 Jul; 67(3):183-8. PubMed ID: 11391716
[TBL] [Abstract][Full Text] [Related]
17. Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease.
Bereczky Z; Balogh E; Katona E; Czuriga I; Kárpáti L; Shemirani AH; Edes I; Muszbek L
Thromb Res; 2008; 121(4):469-76. PubMed ID: 17597187
[TBL] [Abstract][Full Text] [Related]
18. The homozygous leu variant of the factor XIII Val34Leu polymorphism as a risk factor for the manifestation of thrombotic microangiopathies.
Sucker C; Farokhzad F; Kurschat C; Grabensee B; Scharf RE; Zotz RB; Maruhn-Debowski B; Hetzel GR
Clin Appl Thromb Hemost; 2009; 15(2):197-200. PubMed ID: 17895511
[TBL] [Abstract][Full Text] [Related]
19. A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.
Marín F; González-Conejero R; Lee KW; Corral J; Roldán V; López F; Sogorb F; Caturla J; Lip GY; Vicente V
J Am Coll Cardiol; 2005 Jan; 45(1):25-9. PubMed ID: 15629368
[TBL] [Abstract][Full Text] [Related]
20. Association of the A/G polymorphism at position 49 in exon 1 of CTLA-4 with the susceptibility to unexplained recurrent spontaneous abortion in the Chinese population.
Wang X; Lin Q; Ma Z; Hong Y; Zhao A; Di W; Lu P
Am J Reprod Immunol; 2005 Feb; 53(2):100-5. PubMed ID: 15790344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
